Class: Expansion (424)
Patent Number: 6720340
This patent teaches that nicotine may be used for mobilization of stem cells. It covers endothelial precursor cells as well.
Inventors: Cooke, John (Palo Alto, CA); Johnson, Frances Lauri (Portola Valley, CA); Pathak, Anjali (Campbell, CA); Jang, James (San Bruno, CA); Tsao, Phillip (San Jose, CA); Heeschen, Christopher (Menlo Park, CA)
Assignee: The Board of Trustees of the Leland Stanford, Jr. Unversity (Palo Alto, CA)
Date of First Priority Issue: Wednesday July 28th, 1999
Patent Number: 7056885
The invention covers a novel type of fibroblast growth factor called FGF-CX, which is useful for differentiation and expansion of various stem cells. The patent has 2 independent claims: 1 for the composition of matter itself, and the second for the composition of matter together with a pharmaceutically applicable carrier.
Inventors: Jeffers, Michael (Branford, CT); Shimkets, Richard A. (West Haven, CT); Prayaga, Sudhirdas K. (East Haven, CT); Boldog, Ferenc L. (North Haven, CT); Yang, Meijia (East Lyme, CT); Burgess, Catherine (Wethersfield, CT); Fernandes, Elma (Branford, CT); Herrm
Assignee: CuraGen Corporation (Branford, CT)
Date of First Priority Issue: Tuesday July 27th, 1999
Patent Number: 7,459,541
This patent covers a series of fusion proteins that are generated with selectively to bind collagen. The inventors believe that since various forms of collagen are exposed during injury, the specific targeting of "repair" proteins to the injuried tissue will augment the healing process.
Specifically the inventors target the "repair proteins": insulin...
Inventors: Hall; Frederick L. (Glendale, CA), Gordon; Erlinda M. (Glendale, CA), Beart; Robert W. (Pasadena, CA), Nimni; Marcel (Santa Monica, CA)
Assignee: University of Southern California (Los Angeles, CA)
Date of First Priority Issue: Wednesday July 21st, 1999
Patent Number: 6465248
This patent teaches ways how to culture neurons in order to obtain certain phenotypes. One type of neuron that is obtained by using the culture conditions thought by this invention is a dopamine secreting neuron.
This invention is owned by the company Prescient NeuroPharma which appears to be a Canadian venture-backed company.
Inventor: Commissiong, John (Mississauga, CA)
Assignee: Prescient NeuroPharma, Inc. (Toronto, CA)
Date of First Priority Issue: Friday July 16th, 1999
Patent Number: 6361998
This patent teaches how to generate large amounts of erythrocytes by specifically culturing hematopoietic stem cells with cytokines such as IL-3, Stem Cell Factor, and EPO.
Inventors: Bell, David N. (Oakville, CA); Matthews, Kathryn Emma (Toronto, CA); Mueller, Susan G. (Milton, CA)
Assignee: Hemosol Inc. (Mississauga, CA)
Date of First Priority Issue: Friday June 25th, 1999
Patent Number: 6821513
Inventor: Fleming, William H. (Portland, OR)
Assignee: Oregon Health & Science University (Portland, OR)
Date of First Priority Issue: Wednesday June 23rd, 1999
Patent Number: 6759245
Ex vivo culture of stem cells is important for the generation of artificial organs. This patent teaches culture of stem cells and precursor cells using a unique culture set up that allows for proper differentiation of cells in an in vivo like setting. The patent is primarily targeted towards the generation of hepatocytes.
Inventors: Toner, Mehmet (Wellesley, MA); Tilles, Arno W. (Cambridge, MA); Balis, Ulysses J. (Peabody, MA); Yarmush, Martin L. (Newton, MA); Cosman, Maury D. (Woburn, MA); Dimilla, Paul A. (Dover, MA)
Assignee: The General Hospital Corporation (Boston, MA); Organogenesis Inc. (Canton, MA)
Date of First Priority Issue: Monday June 21st, 1999
Patent Number: 6372494
This patent teaches how to generate cell conditioned media. The unique part about this patent is that the cells used to condition the media are grown in three dimensional culture.
Inventors: Naughton, Gail K. (La Jolla, CA); Mansbridge, Jonathan N. (La Jolla, CA); Pinney, R. Emmett (Poway, CA) )
Assignee: Advanced Tissue Sciences, Inc. (La Jolla, CA)
Date of First Priority Issue: Friday May 14th, 1999
Patent Number: 6858646
Oxidative stress plays a very important role in the ability of stem cells to survive. Specifically, stem cells prefer to reside in areas of relative hypoxia, and are particularly senstive to oxidative stress. This patent teaches that use of pyruvate, and other antioxidants in order to protect neurons, and stem cells of neurons, from damage.
This patent may be used to treat, for example...
Inventors: Paquin, Joanne (Montreal, CA); Mateescu, Mircea-Alexandru (Montreal, CA); De Grandpre , Eric (Joliette, CA)
Assignee: Universite du Quebec a Montreal (Montreal, CA)
Date of First Priority Issue: Wednesday May 5th, 1999
Patent Number: 6866991
This patent describes the use of zvegf3, a platelet derived growth factor homologue for expansion of various stem cells, including bone marrow stem cells.
Inventors: Gilbertson, Debra G. (Seattle, WA); Hart, Charles E. (Woodinville, WA)
Assignee: ZymoGenetics, Inc. (Seattle, WA)
Date of First Priority Issue: Monday May 3rd, 1999